Anastrozole vs Exemestane
A clean factual split between two ancillaries that get compared constantly. The mechanism difference is real and easy to state without giving any dosing guidance.
Side by side
| Anastrozole | Exemestane | |
|---|---|---|
| Class | Ancillaries | Ancillaries |
| Form | Oral | Oral |
| Half-life | ≈ 2.1 days (50 h) | ≈ 24 hours |
| Storage | Room temperature | Room temperature |
| Dose units | mg | mg |
| FDA status | Approved | Approved |
Facts from the Stack compound library. See the full pages: Anastrozole · Exemestane.
How they differ
Class
Anastrozole is non-steroidal and binds the aromatase enzyme reversibly. Exemestane is steroidal and binds irreversibly — the enzyme has to be remade. Same target, different chemistry.
Practical implication
The reversible-vs-irreversible difference is the main thing people mean when they compare these. How that maps to any individual's use is strictly a clinician's call.
Tracking
Both are orals taken on a schedule alongside other compounds; both fit cleanly into a protocol group you can pause as a unit.
Status
See each entry for FDA status — stated plainly on every library page.
Tracking either one
Whichever you log, the workflow is the same in Stack: add it once, set the schedule, and let the app handle reminders, supply projection and an "in your system" curve from the half-life. Run both? Group them into one protocol you can pause together.
Track your stack in Stack
Free, private, no account. Doses, schedules, supply and trends in one quiet app.
Get the appLast reviewed 2026-06-11